Patents Assigned to HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA
  • Method for diagnosing a neurodegenerative disease
    Patent number: 9896729
    Abstract: The present invention relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease comprising determining whether the subject has a mutation in the C9orf72 gene wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: February 20, 2018
    Assignees: The University of Manchester, National Institute of Aging, Hospital District of Helsinki and UUSIMAA, VU University Medical Centre Armsterdam, UCL Business PLC, University College Cardiff Consultants Limited
    Inventors: Stuart Pickering-Brown, Bryan Traynor, Andrew B. Singleton, Huw Morris, Peter Heutink, John Hardy, Pentti Tienari
  • METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE
    Publication number: 20150252421
    Abstract: The present invention relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease comprising determining whether the subject has a mutation in the C9orf72 gene wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.
    Type: Application
    Filed: August 31, 2012
    Publication date: September 10, 2015
    Applicants: THE UNIVERSITY OF MANCHESTER, NATIONAL INSTITUTE ON AGING, HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA, VU UNIVERSITY MEDICAL CENTRE AMSTERDAM, UCL BUSINESS PLC, UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Stuart Pickering-Brown, Bryan Traynor, Andrew B. Singleton, Huw Morris, Peter Heutink, John Hardy, Pentti Tienari